Cocrystal Pharma Inc — Dividend History & Yield (NASDAQ:COCP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Haberler

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma raises $4.7 million in registered direct offering

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study

H.C. Wainwright lowers Cocrystal Pharma stock price target on dilution

Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference

Cocrystal’s flu drug shows promise against H5N1 strain

Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs